Gentas Kimya Sanayi ve Ticaret Pazarlama

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama carries a market capitalization of 8.34B, placing it among publicly traded companies globally. Its enterprise value stands at 7.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama has 609.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.78, and the price-to-book ratio stands at 1.19.

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama trades at an EV/EBITDA multiple of 10.41 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.69 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.96 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 7.55B versus a market cap of 8.34B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama maintains a current ratio of 3.17, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.34, indicating elevated leverage, while an interest coverage ratio of 3.33 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 32.56M in revenue per employee across its workforce of 137.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama recorded 234.48M in income tax expense. That works out to an effective tax rate of 140.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 166.61M, leaving -67.86M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama generated 4.46B in revenue and converted that into -67.86M in net income, yielding earnings per share of -0.12. EBITDA reached 725.07M, while operating income came in at 630.97M.

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama holds 1.03B in cash and equivalents against 235.00M in total debt, resulting in a net debt position of -796.07M. Total book value stands at 7.03B, with working capital of 2.38B providing operational flexibility.

Gentas Kimya Sanayi ve Ticaret Pazarlama produced 102.94M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -71.67M in capital expenditures, free cash flow totaled 31.27M - equivalent to 0.05 per share.

Over the twelve months ended June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama posted a gross margin of 23.11, reflecting its pricing power and cost economics. The operating margin of 14.15 and net profit margin of -1.52 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 0.39, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -5.99, meaning Gentas Kimya Sanayi ve Ticaret Pazarlama raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Gentas Kimya Sanayi ve Ticaret Pazarlama has an Altman Z-Score of 4.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.